Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heterozygous Familial Hypercholesterolemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01576484
What this trial is testing

Open-Label Extension of Study R727-CL-1003 (NCT01266876) to Evaluate the Long-Term Safety and Efficacy of Alirocumab (REGN727) in Participants With Heterozygous Familial Hypercholesterolemia (HeFH)

Who this might be right for
HypercholesterolemiaHeterozygous Familial Hypercholesterolemia
Regeneron Pharmaceuticals 58
Large-scale testing (Phase 3)Study completedNCT00654446
What this trial is testing

IIIb 6 Week Open Label Multicentre Rosuvastatin & Simvastatin

Who this might be right for
Fredrickson Type IIa & Type IIb Dyslipidaemia
AstraZeneca 442
Large-scale testing (Phase 3)Study completedNCT01824238
What this trial is testing

The Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-050)

Who this might be right for
Heterozygous Familial Hypercholesterolemia (HeFH)
Merck Sharp & Dohme LLC 68
Testing effectiveness (Phase 2)Study completedNCT01266876
What this trial is testing

Study of the Safety and Efficacy of REGN727/SAR236553 in Patients With HeFH Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
Regeneron Pharmaceuticals 77
Large-scale testing (Phase 3)Study completedNCT02666664
What this trial is testing

Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)

Who this might be right for
HypercholesterolemiaAtherosclerotic Cardiovascular Diseases
Esperion Therapeutics, Inc. 2,230
Not applicableUnknownNCT01783405
What this trial is testing

Cardiovascular Disease in FH Heterozygous

Who this might be right for
Familial Hypercholesterolemia
Sociedad Española de Arteriosclerosis 1,100
Not applicableStudy completedNCT05181553
What this trial is testing

Unravelling the Impact of Diet on Cardiovascular Health in Heterozygous Familial Hypercholesterolemia.

Who this might be right for
Familial HypercholesterolemiaNutrition, HealthyCholesterol, Elevated+2 more
Laval University 50
Testing effectiveness (Phase 2)Study completedNCT00477594
What this trial is testing

Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia

Who this might be right for
Lipid Metabolism, Inborn ErrorsHypercholesterolemia, Autosomal DominantHyperlipidemias+11 more
Kastle Therapeutics, LLC 21
Large-scale testing (Phase 3)Study completedNCT00552097
What this trial is testing

Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578)

Who this might be right for
AtherosclerosisHypercholesterolemiaHyperlipoproteinemia Type II
Organon and Co 720
Large-scale testing (Phase 3)Study completedNCT02460159
What this trial is testing

A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384)

Who this might be right for
HypercholesterolemiaHeterozygous Familial Hypercholesterolemia
Organon and Co 135
Post-approval studies (Phase 4)Ended earlyNCT03694197
What this trial is testing

Long Term Safety Study of PRALUENT

Who this might be right for
Heterozygous Familial HypercholesterolemiaNon-familial Hypercholesterolemia
Regeneron Pharmaceuticals 1,389
Not applicableStudy completedNCT02976818
What this trial is testing

Lp(a) and Aortic Valve Calcification

Who this might be right for
Heterozygous Familial Hypercholesterolemia
Laval University 173
Early research (Phase 1)Looking for participantsNCT06164730
What this trial is testing

VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease

Who this might be right for
Heterozygous Familial HypercholesterolemiaPremature Coronary Heart Disease
Verve Therapeutics, Inc. 85
Large-scale testing (Phase 3)Looking for participantsNCT06597019
What this trial is testing

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

Who this might be right for
Familial Hypercholesterolemia - Heterozygous
Novartis Pharmaceuticals 60
Not applicableLooking for participantsNCT06634160
What this trial is testing

Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozygous Familial Hypercholesterolemia

Who this might be right for
Heterozygous Familial Hypercholesterolemia
Nantes University Hospital 200
Large-scale testing (Phase 3)Enrolling By InvitationNCT07102511
What this trial is testing

Study to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With Heterozygous FH

Who this might be right for
Familial Hypercholesterolemia - Heterozygous
LIB Therapeutics LLC 150
Testing effectiveness (Phase 2)Study completedNCT04173793
What this trial is testing

PCSK9 Inhibitor AK102 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)

Who this might be right for
Heterozygous Familial Hypercholesterolemia
Akeso 109
Large-scale testing (Phase 3)Study completedNCT00171236
What this trial is testing

Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia

Who this might be right for
Heterozygous Familial HypercholesterolemiaMixed Dyslipidemia
Novartis 84
Large-scale testing (Phase 3)Study completedNCT01475825
What this trial is testing

The Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Who this might be right for
HypercholesterolemiaHeterozygous Familial
Kastle Therapeutics, LLC 309
Large-scale testing (Phase 3)Study completedNCT01968980
What this trial is testing

A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia

Who this might be right for
Heterozygous Familial Hypercholesterolemia
Pfizer 370
Next Page